All conditions

Neuropathic pain

Tracking and physiotherapy support for adults living with neuropathic pain in Australia, including sciatica, diabetic neuropathy and post-herpetic neuralgia. Pain Coach is designed to be used alongside your GP, neurologist, pain specialist or physiotherapist, not in place of one.

What is neuropathic pain?

Neuropathic pain is pain caused by a lesion or disease of the somatosensory nervous system: the nerves and brain pathways that carry sensory signals from the body1,2. It is one of three main categories of chronic pain, alongside nociceptive pain (from tissue damage) and nociplastic pain (from changes in central pain processing without identifiable injury), and it is estimated to affect roughly 7–10% of the general population3,4. In Australia, where one in five adults lives with chronic pain, neuropathic features are present in a substantial fraction5.

Neuropathic pain often has a distinctive quality. People typically describe it as burning, shooting, electric, stabbing, or like pins and needles, and it may be accompanied by numbness or unusual sensitivity, where light touch or temperature changes feel painful (allodynia), or normal pain feels much worse than expected (hyperalgesia)3. These descriptive features are often the first clue that pain is neuropathic rather than coming from a muscle, joint or organ.

Many conditions can cause neuropathic pain. The most common include:

  • Painful diabetic peripheral neuropathy. The most common cause globally, affecting up to half of people with long-standing diabetes3.
  • Sciatica and lumbosacral radiculopathy. Pain radiating down the leg from compression or irritation of nerve roots in the lower back.
  • Post-herpetic neuralgia. Persistent pain after a shingles episode.
  • Trigeminal neuralgia. Severe facial pain from the trigeminal nerve.
  • Chemotherapy-induced peripheral neuropathy. Nerve damage caused by neurotoxic chemotherapy agents.
  • Post-surgical and post-traumatic neuropathic pain. Nerve damage occurring during surgery or injury.
  • Central neuropathic pain. Pain from stroke, multiple sclerosis or spinal cord injury.

Neuropathic pain is real and treatable, though often only partially

Compared with conditions where pain has no visible cause, neuropathic pain usually has an identifiable mechanism that can be detected with the right examination, imaging or nerve studies. Pain medicine has formal diagnostic criteria for neuropathic pain (the NeuPSIG grading system distinguishes possible, probable and definite neuropathic pain) and an established treatment hierarchy with evidence behind each step2,6.

Neuropathic pain also comes with its own difficult truth. Across the major drug classes used for neuropathic pain (tricyclic antidepressants, gabapentinoids, serotonin-noradrenaline reuptake inhibitors and topical agents), only around a third to a half of patients achieve clinically meaningful pain relief on any one drug, and the typical reduction is partial rather than complete6,7. This is not a failing on anyone's part. It reflects how difficult it is to fully reverse changes in nerve function once they have set in.

In practice, the goal of treatment is usually meaningful improvement (better function, less interference with sleep, more participation in life) rather than complete pain elimination. Knowing this in advance changes how people experience treatment. Patients who go in expecting partial improvement and incremental progress tend to feel better served than those expecting a cure. The aim is to make the pain a smaller part of your day, not no part of it.

What current evidence says about neuropathic pain care

Current guidance from the International Association for the Study of Pain's Special Interest Group on Neuropathic Pain (NeuPSIG), the European Academy of Neurology, and Australian primary care guidance from the RACGP and Australian Pain Society recommends a stepped, multimodal approach6,7,8,9.

First-line medications are tricyclic antidepressants (such as amitriptyline or nortriptyline), gabapentinoids (gabapentin and pregabalin) and serotonin-noradrenaline reuptake inhibitors (such as duloxetine)6. Second-line options include tramadol and topical agents such as lidocaine patches or high-dose capsaicin patches. Strong opioids (such as oxycodone or morphine) are generally a last resort, given limited long-term effectiveness in neuropathic pain and substantial harm potential6. Specific medication choice depends on the type of neuropathic pain, other conditions and tolerance of side effects, and is best made with a GP, neurologist or pain specialist.

Disease-specific treatments matter as much as symptom control. For diabetic neuropathy, glycaemic control slows progression and is part of pain management3. For acute herpes zoster (shingles), early antiviral treatment reduces the risk of post-herpetic neuralgia. For sciatica from a disc herniation, most cases improve substantially with conservative management over weeks to months; surgery is considered for severe or progressive neurological deficits.

Non-pharmacological treatments complement medication rather than replace it. Physiotherapy has a role for radicular pain (nerve gliding techniques and graded exercise), for diabetic neuropathy (balance training, gait and foot care) and for central neuropathic pain (graded motor imagery and mirror therapy in selected cases)10. Psychological support, particularly cognitive behavioural therapy, has consistent evidence for reducing the distress, fear and disability that often accompany neuropathic pain11,12. Patient education about how the nervous system generates pain after nerve injury helps people make sense of their experience and approach treatment with realistic expectations10.

How Pain Coach is built for neuropathic pain

Pain Coach is a chronic pain tracking app designed to be used with your GP, neurologist, pain specialist or physiotherapist. For neuropathic pain, the daily check-in captures pain alongside the five lifestyle factors that influence chronic pain (sleep, exercise, nutrition, stress and social connection) in under two minutes a day.

Three things about neuropathic pain make tracking particularly useful. First, medication response takes weeks to evaluate, and many people need to try more than one agent before finding what works for them. Knowing exactly when a medication was started, at what dose, and what happened to pain and function over the following weeks is the only reliable way to judge effect; memory tends to compress this6. Second, side effects from neuropathic-pain medications are common (sedation, weight gain, dizziness, dry mouth), and tracking them daily makes it easier to tell side effects apart from underlying symptoms and from coincidental changes. Third, the gap between pain and function can be wide in neuropathic pain: many people remain in some pain but regain substantial function with the right combination of treatment, sleep and graded activity. Tracking function alongside pain is the only way to see this progress clearly10.

Pain Coach does not promise a cure. For most types of neuropathic pain, the realistic goal is meaningful improvement across months rather than elimination, and tracking is what lets you and your clinician see when meaningful improvement is happening6.

The five lifestyle factors and neuropathic pain

Each of the five factors Pain Coach tracks affects neuropathic pain, with some interactions specific to this category.

  • Sleep. Neuropathic pain is particularly disruptive to sleep: the burning or electric quality often worsens at night, and sleep loss in turn amplifies central pain processing13,14. Several first-line neuropathic pain medications (such as amitriptyline and gabapentinoids) are taken at night specifically to take advantage of sedative effects on sleep6. Tracking sleep alongside pain often reveals how much of the daytime symptom load is downstream of poor sleep.
  • Exercise and movement. Graded movement supports nerve health and is recommended for most types of neuropathic pain, with the strongest evidence base in diabetic neuropathy, where regular exercise improves both glycaemic control and neuropathy outcomes15,3. For radicular pain such as sciatica, gradual return to movement is usually more helpful than prolonged rest. The key word is graded: starting below current tolerance and building slowly. Pain Coach shows your clinician what you actually sustained.
  • Nutrition. For diabetic neuropathy specifically, glycaemic control is part of pain management, and that depends substantially on what you eat3. For chronic musculoskeletal pain more broadly, regular, balanced eating supports energy, mood and recovery16. Pain Coach tracks plant intake, whole-food intake and added sugar so your clinician can see the pattern; it does not prescribe a specific diet.
  • Stress. Persistent stress amplifies central pain processing, and in chronic neuropathic pain, central sensitisation often develops alongside the original nerve injury17,18. Fear of activity and unhelpful beliefs about pain (particularly the belief that any pain means damage) can amplify the experience12. Psychological support has consistent evidence for reducing distress and disability in chronic pain, including neuropathic pain11.
  • Social connection. Neuropathic pain is often invisible: there is no cast, no obvious scar to explain why someone is functioning poorly. Isolation and loneliness independently worsen chronic pain outcomes, and social pain shares neural pathways with physical pain19,20. Small, regular contact with people who understand the condition tends to correlate with better days.

Find a neuropathic pain physiotherapist in Australia

Pain Coach Connect lists verified Australian physiotherapists who work with neuropathic pain, with telehealth and in-person consultations available. Different types of neuropathic pain benefit from different physiotherapy approaches: nerve gliding and graded exercise for radicular pain such as sciatica, balance and gait work for peripheral neuropathy, and graded motor imagery or mirror therapy for some central neuropathic pain presentations10. The listings are filtered to physiotherapists with specific experience in these areas.

Where neuropathic pain is moderate to severe, has been present for more than a few months, or is not responding to first-line treatment from your GP, referral to a pain specialist or neurologist is usually the appropriate next step. Pain medicine is a distinct specialty in Australia, with pain clinics in most major hospitals and a growing network of pain medicine physicians in private practice. Your GP can refer you.

Next step

Find a chronic pain physiotherapist near you

Search verified Australian chronic pain physiotherapists. Telehealth and in-person, Medicare CDM plans accepted by participating clinics.

Search Pain Coach Connect

Common questions

References

  1. Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19-27. doi:10.1097/j.pain.0000000000001384.Read
  2. Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 2016;157(8):1599-1606. doi:10.1097/j.pain.0000000000000492.Read
  3. Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nature Reviews Disease Primers. 2017;3:17002. doi:10.1038/nrdp.2017.2.Read
  4. van Hecke O, Austin SK, Khan RA, et al. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654-662. doi:10.1016/j.pain.2013.11.013.Read
  5. Australian Institute of Health and Welfare. Chronic pain in Australia. AIHW; 2020.Read
  6. Soliman N, Moisset X, Ferraro MC, et al. Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis. The Lancet Neurology. 2025;24(5):413-428. doi:10.1016/S1474-4422(25)00068-7.Read
  7. Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. The Lancet Neurology. 2015;14(2):162-173. doi:10.1016/S1474-4422(14)70251-0.Read
  8. Royal Australian College of General Practitioners. Management of chronic pain. 2024.
  9. Australian Pain Society. Position statements on the management of chronic pain. 2023.
  10. Moseley GL, Butler DS. Fifteen years of explaining pain: the past, present, and future. The Journal of Pain. 2015;16(9):807-813. doi:10.1016/j.jpain.2015.05.005.Read
  11. Williams ACDC, Fisher E, Hearn L, et al. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database of Systematic Reviews. 2020(8):CD007407. doi:10.1002/14651858.CD007407.pub4.Read
  12. Vlaeyen JWS, Crombez G, Linton SJ. The fear-avoidance model of pain. Pain. 2016;157(8):1588-1589. doi:10.1097/j.pain.0000000000000574.Read
  13. Finan PH, Goodin BR, Smith MT. The association of sleep and pain: an update and a path forward. The Journal of Pain. 2013;14(12):1539-1552. doi:10.1016/j.jpain.2013.08.007.Read
  14. Alföldi P, Dragioti E, Wiklund T, et al. Spreading of pain and insomnia in patients with chronic pain: results from a national quality registry (SQRP). Scandinavian Journal of Pain. 2017;16:96-103. doi:10.1016/j.sjpain.2017.04.069.Read
  15. World Health Organization. WHO guidelines on physical activity and sedentary behaviour. 2020.Read
  16. Elma Ö, Yilmaz ST, Deliens T, et al. Do nutritional factors interact with chronic musculoskeletal pain? A systematic review. Journal of Clinical Medicine. 2020;9(3):702. doi:10.3390/jcm9030702.Read
  17. Crofford LJ. Chronic pain: where the body meets the brain. Transactions of the American Clinical and Climatological Association. 2015;126:167-183.
  18. Kosek E, Clauw D, Nijs J, et al. Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain. 2021;162(11):2629-2634. doi:10.1097/j.pain.0000000000002324.Read
  19. Karayannis NV, Baumann I, Sturgeon JA, et al. The impact of social isolation on pain interference. Annals of Behavioral Medicine. 2019;53(1):65-74. doi:10.1093/abm/kay017.Read
  20. Eisenberger NI. The pain of social disconnection: examining the shared neural underpinnings of physical and social pain. Nature Reviews Neuroscience. 2012;13(6):421-434. doi:10.1038/nrn3231.Read

Last reviewed 21 May 2026 by Lachlan Townend. Pain Coach reviews all clinical content at least once every twelve months.